About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Slc8b1tm1c(EUCOMM)Wtsi
targeted mutation 1c, Wellcome Trust Sanger Institute
MGI:5909410
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Slc8b1tm1c(EUCOMM)Wtsi/Slc8b1tm1c(EUCOMM)Wtsi
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
involves: 129S4/SvJaeSor * C57BL/6N * FVB/N MGI:7316564
cn2
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Ppiftm1Jmol/Ppiftm1Jmol
Slc8b1tm1c(EUCOMM)Wtsi/Slc8b1tm1c(EUCOMM)Wtsi
involves: 129S4/SvJaeSor * C57BL/6N * FVB/N MGI:7316565


Genotype
MGI:7316564
cn1
Allelic
Composition
Slc8b1tm1c(EUCOMM)Wtsi/Slc8b1tm1c(EUCOMM)Wtsi
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Genetic
Background
involves: 129S4/SvJaeSor * C57BL/6N * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
A1cfTg(Myh6-cre/Esr1*)1Jmk mutation (5 available); any A1cf mutation (39 available)
Slc8b1tm1c(EUCOMM)Wtsi mutation (1 available); any Slc8b1 mutation (47 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• most mice died within two weeks of tamoxifen treatment

cardiovascular system
• increased cross-sectional area post tamoxifen-treatment
• post tamoxifen-treatment
• post tamoxifen-treatment
• 3 days post tamoxifen-treatment
• post tamoxifen-treatment
• decreased left ventricular function 3 days post tamoxifen-treatment as measured by fractional shortening and left ventricular end-diastolic dimension
• post tamoxifen-treatment
• post tamoxifen-treatment only immediately before sinus arrest
• post tamoxifen-treatment
• post tamoxifen-treatment
• post tamoxifen-treatment

growth/size/body
• post tamoxifen-treatment
• post tamoxifen-treatment

muscle
• increased cross-sectional area post tamoxifen-treatment
• decreased left ventricular function 3 days post tamoxifen-treatment as measured by fractional shortening and left ventricular end-diastolic dimension
• disorganized post tamoxifen-treatment

cellular
• with disrupted calcium regulation in cardiomyocytes post tamoxifen-treatment




Genotype
MGI:7316565
cn2
Allelic
Composition
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Ppiftm1Jmol/Ppiftm1Jmol
Slc8b1tm1c(EUCOMM)Wtsi/Slc8b1tm1c(EUCOMM)Wtsi
Genetic
Background
involves: 129S4/SvJaeSor * C57BL/6N * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
A1cfTg(Myh6-cre/Esr1*)1Jmk mutation (5 available); any A1cf mutation (39 available)
Ppiftm1Jmol mutation (1 available); any Ppif mutation (20 available)
Slc8b1tm1c(EUCOMM)Wtsi mutation (1 available); any Slc8b1 mutation (47 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• near complete rescue in tamoxifen-treated mice
• near complete rescue in tamoxifen-treated mice

growth/size/body
• near complete rescue in tamoxifen-treated mice

muscle
• near complete rescue in tamoxifen-treated mice
• disorganization is nearly completely rescued in tamoxifen-treated mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory